Nasus Pharma LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
AMEX
NSRX
Nasus Pharma LTDDan Benjamin Teleman, Chief Executive Officer and a Director of Nasus Pharma Ltd, reported multiple transactions in common stock on July 22, 2026.
AMEX
NSRX
Nasus Pharma LTDCEO Dan Benjamin Teleman purchased 2,900 ordinary shares of Nasus Pharma Ltd at $3.76 per share, signaling executive confidence.
AMEX
NSRX
Nasus Pharma LTDNasus Pharma Ltd's CEO, Dan Benjamin Teleman, acquired 15,000 ordinary shares at $2.04 each, increasing his direct beneficial ownership.